Paper3933501
Cytochrome P450 dependent metabolism of arachidonic acid in bovine corneal epithelium.
Schwartzman ML and 4 others. Biochem Biophys Res Commun, 1985. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Cytochrome P450 dependent metabolism of arachidonic acid in bovine corneal epithelium. Papers, record 3933501. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3933501
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arachidonic Acids | Major topic |
| Cornea | Major topic |
| Cytochrome P-450 Enzyme System | Major topic |
| Animals | |
| Arachidonic Acid | |
| Aryl Hydrocarbon Hydroxylases | |
| Carbon Monoxide | |
| Cattle | |
| Chromatography, Thin Layer | |
| Epithelium | |
| Microsomes | |
| NADP | |
| Proadifen |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AM 29742 | NIADDK NIH HHS | United States | R01AM029742 | PubMed and NIH | NIH RePORTER |
| AM00781 | NIADDK NIH HHS | United States | PubMed | PubMed | |
| HL 25394-NHLBI | NHLBI NIH HHS | United States | PubMed | PubMed | |
| R01HL025394 | NIH | NIH RePORTER | |||
| R37HL025394 | NIH | NIH RePORTER |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38540794 | Role of Polyunsaturated Fatty Acids (PUFAs) and Eicosanoids on Dry Eye Symptoms and Signs. | Biomolecules | 2024 | https://conductscience.org/library/papers/38540794 | PubMed |
| 28322972 | Potential role of CYP1B1 in the development and treatment of metabolic diseases. | Pharmacol Ther | 2017 | https://conductscience.org/library/papers/28322972 | PubMed |
| 25189712 | The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China. | Lipids Health Dis | 2014 | https://conductscience.org/library/papers/25189712 | PubMed |
| 19965607 | Significance of lipid mediators in corneal injury and repair. | J Lipid Res | 2010 | https://conductscience.org/library/papers/19965607 | PubMed |
| 17851396 | Phase I and phase II ocular metabolic activities and the role of metabolism in ophthalmic prodrug and codrug design and delivery. | Molecules | 2007 | https://conductscience.org/library/papers/17851396 | PubMed |
| 2825178 | 12(R)-hydroxyicosatetraenoic acid: a cytochrome-P450-dependent arachidonate metabolite that inhibits Na+,K+-ATPase in the cornea. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/2825178 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3933501
GET https://conductscience.org/api/papers/v1/3933501/authors